A phase 2 single-arm study of the clinical activity and safety of enzalutamide in patients with advanced androgen receptor-positive triple-negative breast cancer Meeting Abstract
| Authors: | Traina, T. A.; O'Shaughnessy, J.; Kelly, C. M.; Schwartzberg, L. S.; Gucalp, A.; Peterson, A. C.; Tudor, I. C.; Blaney, M. E.; Steinberg, J. L.; Trudeau, M. E.; Hudis, C. A.; Schmid, P. |
| Abstract Title: | A phase 2 single-arm study of the clinical activity and safety of enzalutamide in patients with advanced androgen receptor-positive triple-negative breast cancer |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613202007 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.TPS1144 |
| Notes: | Meeting Abstract: TPS1144 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
